Skip to main content

Table 2 Details of AEs in LM patients who underwent PTNB

From: Personalized drug screening of patient-derived tumor-like cell clusters based on specimens obtained from percutaneous transthoracic needle biopsy in patients with lung malignancy: a real-world study

Variables

Overall (n = 68)

Overall AEs

18(26.5%)

 Grade 1

  Pneumothorax

8(11.8%)

  Pleural effusion

2(2.9%)

  Chest pain or congestion

3(4.4%)

  Hemorrhage

4(5.9%)

 Grade 2

  Pneumothorax

6(8.8%)

  Pleural effusion

3(4.4%)

  Chest pain or congestion

1(1.5%)

  Hemorrhage

2(2.9%)

  1. AEs = Adverse events. LM = Lung malignancy. PTNB = Percutaneous transthoracic needle biopsy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us